New technologies for new drug discovery processes are emerging rapidly in the Post-Genome era. The company assists technology companies operating outside Japan finding a new business collaboration with Japanese pharmaceutical firms in the field of new drug discovery.

Biolink International, Inc. assists in the following areas:

• Evaluation of novel platform technology for Japanese market
• Assistance in negotiation of technology license
• Follow-up to assure compliance with agreement

Consulting service which the company has provided are:.

• Industrial Proteomics Technology for fee-for-service in Japan
• Introduction of new process chemistry technologies to Japanese pharmaceutical firms

Please contact us to discuss further details of our services.